BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21502672)

  • 1. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community.
    Onyekwere CA; Ogbera AO; Balogun BO
    Ann Hepatol; 2011; 10(2):119-24. PubMed ID: 21502672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.
    Olusanya TO; Lesi OA; Adeyomoye AA; Fasanmade OA
    Pan Afr Med J; 2016; 24():20. PubMed ID: 27583084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital.
    Mondal E; Karim MR; Begum A; Hassan K; Noor SM; Khan MM; Khan KH; Ashrafuzzaman SM
    Mymensingh Med J; 2023 Apr; 32(2):338-347. PubMed ID: 37002743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.
    Agarwal AK; Jain V; Singla S; Baruah BP; Arya V; Yadav R; Singh VP
    J Assoc Physicians India; 2011 Jun; 59():351-4. PubMed ID: 21751587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
    Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
    Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease].
    Xu JY; Shao Y; Lu XL; Deng J; Li XL; Shi HT
    Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):204-209. PubMed ID: 30929337
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China.
    Yan J; Xie W; Ou WN; Zhao H; Wang SY; Wang JH; Wang Q; Yang YY; Feng X; Cheng J
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1654-9. PubMed ID: 23731053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.
    Hamaguchi M; Takeda N; Kojima T; Ohbora A; Kato T; Sarui H; Fukui M; Nagata C; Takeda J
    World J Gastroenterol; 2012 Apr; 18(13):1508-16. PubMed ID: 22509083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
    Prasetya IB; Hasan I; Wisnu W; Rumende CM
    Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
    Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
    Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia: high risk status and low prevalence.
    George ES; Roberts SK; Nicoll AJ; Reddy A; Paris T; Itsiopoulos C; Tierney AC
    Intern Med J; 2018 Nov; 48(11):1369-1376. PubMed ID: 29845719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.
    Bajaj S; Nigam P; Luthra A; Pandey RM; Kondal D; Bhatt SP; Wasir JS; Misra A
    Indian J Med Res; 2009 Mar; 129(3):285-92. PubMed ID: 19491421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.
    Lee SW; Lee TY; Yang SS; Peng YC; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):176-180. PubMed ID: 28381382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran.
    Mansour-Ghanaei F; Joukar F; Mobaraki SN; Mavaddati S; Hassanipour S; Sepehrimanesh M
    Diabetes Metab Syndr; 2019; 13(2):1591-1596. PubMed ID: 31336526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.